Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome

被引:22
作者
Gagnon, Claudia [1 ]
Baillargeon, Jean-Patrice [1 ]
机构
[1] Univ Sherbrooke, Dept Med, Div Endocrinol, Sherbrooke, PQ J1H 5N4, Canada
关键词
D O I
10.1503/cmaj.060607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The Canadian and American Diabetes Associations recommend the use of an oral glucose tolerance test to screen for abnormal glucose tolerance among women with polycystic ovary syndrome when their fasting plasma glucose level is 5.7 mmol/L or more (Canadian guideline) and 5.6 mmol/L or more (American). Our objective was to determine the predictive value of 5.6 mmol/L as a fasting plasma glucose cutoff for detecting abnormal glucose tolerance in women with polycystic ovary syndrome, and then to define the optimal cutoff for this population. Methods: An oral glucose tolerance test was administered to 105 consecutive women with polycystic ovary syndrome referred to an academic reproductive endocrine clinic. We calculated sensitivity, specificity and likelihood ratios. Results: The sensitivity of a 5.6 mmol/L cutoff was 48% (95% confidence interval [CI] 30%-67%); its specificity, 98.7% (95% CI 96.1%-100%). With this cutoff, 52% of women with polycystic ovary syndrome whose glucose tolerance is abnormal would be missed. The prevalence of abnormal glucose tolerance was 28%, with a positive predictive value of 93% (95% CI 81%-100%) and a negative predictive value of 83% (95% CI 76%-91%). The likelihood ratio for a positive test was 36.7 (95% CI 5.0-267), and for a negative test, 0.5 (95% CI 0.4-0.7). The optimal fasting plasma glucose cutoff value was 5.0 mmol/ L, with a 79% sensitivity (95% CI 65%-94%) and 66% specificity (95% CI 55%-77%). If this cutoff were used, 24% of women with abnormal glucose tolerance would still be missed. Interpretation: The Canadian and American recommendations - of screening for abnormal glucose tolerance with an oral glucose tolerance test only when the results of a fasting plasma glucose test are 5.7 mmol/L (or 5.6 mmol/L) or more - are inappropriate for women with polycystic ovary syndrome. We therefore recommend that all women with polycystic ovary syndrome have an oral glucose tolerance test.
引用
收藏
页码:933 / 938
页数:6
相关论文
共 36 条
[11]   A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile [J].
Diamanti-Kandarakis, E ;
Kouli, CR ;
Bergiele, AT ;
Filandra, FA ;
Tsianateli, TC ;
Spina, GG ;
Zapanti, ED ;
Bartzis, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4006-4011
[12]   PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
DIABETES, 1989, 38 (09) :1165-1174
[13]   EVIDENCE FOR DISTINCTIVE AND INTRINSIC DEFECTS IN INSULIN ACTION IN POLYCYSTIC-OVARY-SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
SHELLEY, DR ;
GREEN, G ;
DOBRJANSKY, A ;
LICHOLAI, T .
DIABETES, 1992, 41 (10) :1257-1266
[14]   Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Liljenquist, DR ;
Kasza, K ;
Azziz, R ;
Legro, RS ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :48-53
[15]   Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Barnes, RB ;
Rosenfield, RL ;
Cavaghan, MK ;
Imperial, J .
DIABETES CARE, 1999, 22 (01) :141-146
[16]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[17]   How to read a paper - Papers that report diagnostic or screening tests [J].
Greenhalgh, T .
BRITISH MEDICAL JOURNAL, 1997, 315 (7107) :540-543
[18]   ENHANCED EARLY INSULIN-RESPONSE TO GLUCOSE IN RELATION TO INSULIN-RESISTANCE IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME AND NORMAL GLUCOSE-TOLERANCE [J].
HOLTE, J ;
BERGH, T ;
BERNE, C ;
BERGLUND, L ;
LITHELL, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1052-1058
[19]   Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study [J].
Knochenhauer, ES ;
Key, TJ ;
Kahsar-Miller, M ;
Waggoner, W ;
Boots, LR ;
Azziz, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) :3078-3082
[20]  
Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512